Arch Therapeutics Inc (ARTH)

$0.25 +0.06 (28.21%)
Market Cap 925,000.00
Revenue (ttm) 80,000.00
Net Income (ttm) -6.98M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -8,725.00%
Debt to Equity Ratio 0.00
Volume 5,900
Avg Vol 9,656
Day's Range N/A - N/A
Shares Out 4.74M
Stochastic %K 100%
Beta 3.46
Analysts Strong Buy
Price Target $1.25

Latest News on ARTH

No data available.